Topcon acquires Henson perimetry products

Article

Leading perimetry screening devices added to company’s portfolio

Topcon Healthcare has acquired the Henson line of perimetry products from Elektron Eye Technology. As part of the acquisition, members of the Elektron staff will transition to Topcon. Product manufacturing will continue to operate from the UK.

Deal terms were not disclosed, but products including Henson 9000 and 7000 are within the range of products being acquired, according to the company.

The optical perimeter, Henson 9000, is used for early glaucoma detection and ongoing monitoring of established loss. Henson 7000 is an affordable, lightweight, mobile perimeter designed to screen for suprathreshold glaucoma in the central field.

“The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio,” said Topcon Healthcare Marketing and Product Design Global VP John Trefethen in a statement.

Related: GenSight Biologics reports results of Lumevoq treatment on LHON patients

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
© 2025 MJH Life Sciences

All rights reserved.